CMS penalized 2,597 hospitals in FY2017 on account of unnecessary readmissions. This year the CMS under HRRP will withhold $528 million in payments in 2017-- an all-time high and an increase of about $108 million from FY 2016. New evidence-based research is coming out every day on recommendations to help reduce unnecessary readmissions. But what can a hospital to do prevent unnecessary readmissions?
One in five hospital discharges is complicated by an adverse event within 30 days and this often leads to visits to the emergency departments and readmissions. Research suggests that anywhere between 44% and 76% of hospital readmissions are thought to be preventable. Not only do readmissions occur frequently but they are costly. MedPac has estimated that hospital readmissions cost about $15 billion to Medícare.
The federal law known as the IMPACT Act, is now in effect and has resulted in reduced payments to hospitals that have a higher than average readmission rate for acute myocardial infarction (AMI), heart failure and pneumonia patients. It includes chroníc obstructive pulmonary disease (COPD) and patients admitted for elective total knee arthroplásty (TKA) and total hip arthroplásty (THA). The IMPACT Act also brings five additional quality measures and five new things that must be added to the admission assessment.
Join this webinar by expert speaker Sue Dill Calloway, RN, MSN, JD, to discuss the impact of the federal law and get practical strategies to prevent hospital readmissions. It will also discuss what evidence based studies exist and what are being planned in the future to reengineer the discharge process.
The session will talk about discharges including the IMPACT Act, which is supposed to have a great impact on hospitals. This webinar will also discuss the proposed CMS discharge planning standards which are substantial, including new requirements for the transfer form and discharge planning evaluation. Additionally, concerns such as five things in the discharge instructions, sending of discharge summaries to the physícian within 48 hours, medication reconciliation and other important issues will be discussed in this session.
Who Should Attend?
CEO, CFO, Chief Medical Officer, Chief Nursing Officer, Compliance Officers, members of the team to prevent unnecessary hospital readmissions, nurses, pharmacists, nurse educators, joint commission director, director of regulatory affairs, risk managers, hospital legal counsel, Performance improvement director and staff, director of health information management, social workers, discharge planners, transition nurses, nurse educators, patient safety officers, PI Director, members of the hospital redesign team, and anyone else who is interested in preventing unnecessary hospital readmissions and those involved in discharging patients.
Sue Dill Calloway, RN, MSN, JD, is the president of Patient Safety and Healthcare Consulting and Education company with a focus on medical-legal education especially Joint Commission and the CMS hospital CoPs regulatory compliance. She also lectures on legal, risk management and patient safety issues. She was a director for risk management and patient safety for five years for the Doctors Company. She was the...
More Events By The Speaker